Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?

High fat intake is associated with fat mass gain through fatty acid activation of peroxisome proliferator-activated receptors δ and γ, which promote adipogenesis. We show herein that, compared to a combination of specific agonists to both receptors or to saturated, monounsaturated, and ω-3 polyunsat...

Full description

Bibliographic Details
Main Authors: Florence Massiera, Perla Saint-Marc, Josiane Seydoux, Takahiko Murata, Takuya Kobayashi, Shuh Narumiya, Philippe Guesnet, Ez-Zoubir Amri, Raymond Negrel, Gérard Ailhaud
Format: Article
Language:English
Published: Elsevier 2003-02-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520312141
id doaj-47992fd004a24cb58505437401a59729
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Florence Massiera
Perla Saint-Marc
Josiane Seydoux
Takahiko Murata
Takuya Kobayashi
Shuh Narumiya
Philippe Guesnet
Ez-Zoubir Amri
Raymond Negrel
Gérard Ailhaud
spellingShingle Florence Massiera
Perla Saint-Marc
Josiane Seydoux
Takahiko Murata
Takuya Kobayashi
Shuh Narumiya
Philippe Guesnet
Ez-Zoubir Amri
Raymond Negrel
Gérard Ailhaud
Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?
Journal of Lipid Research
prostacyclin receptor-deficient mice
adipogenesis
pregnancy-lactation
childhood obesity
author_facet Florence Massiera
Perla Saint-Marc
Josiane Seydoux
Takahiko Murata
Takuya Kobayashi
Shuh Narumiya
Philippe Guesnet
Ez-Zoubir Amri
Raymond Negrel
Gérard Ailhaud
author_sort Florence Massiera
title Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?
title_short Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?
title_full Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?
title_fullStr Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?
title_full_unstemmed Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?
title_sort arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2003-02-01
description High fat intake is associated with fat mass gain through fatty acid activation of peroxisome proliferator-activated receptors δ and γ, which promote adipogenesis. We show herein that, compared to a combination of specific agonists to both receptors or to saturated, monounsaturated, and ω-3 polyunsaturated fatty acids, arachidonic acid (C20:4, ω-6) promoted substantially the differentiation of clonal preadipocytes. This effect was blocked by cyclooxygenase inhibitors and mimicked by carbacyclin, suggesting a role for the prostacyclin receptor and activation of the cyclic AMP-dependent pathways that regulate the expression of the CCAAT enhancer binding proteins β and δ implicated in adipogenesis. During the pregnancy-lactation period, mother mice were fed either a high-fat diet rich in linoleic acid, a precursor of arachidonic acid (LO diet), or the same isocaloric diet enriched in linoleic acid and α-linolenic acid (LO/LL diet). Body weight from weaning onwards, fat mass, epididymal fat pad weight, and adipocyte size at 8 weeks of age were higher with LO diet than with LO/LL diet. In contrast, prostacyclin receptor-deficient mice fed either diet were similar in this respect, indicating that the prostacyclin signaling contributes to adipose tissue development.These results raise the issue of the high content of linoleic acid of i) ingested lipids during pregnancy and lactation, and ii) formula milk and infant foods in relation to the epidemic of childhood obesity.
topic prostacyclin receptor-deficient mice
adipogenesis
pregnancy-lactation
childhood obesity
url http://www.sciencedirect.com/science/article/pii/S0022227520312141
work_keys_str_mv AT florencemassiera arachidonicacidandprostacyclinsignalingpromoteadiposetissuedevelopmentahumanhealthconcern
AT perlasaintmarc arachidonicacidandprostacyclinsignalingpromoteadiposetissuedevelopmentahumanhealthconcern
AT josianeseydoux arachidonicacidandprostacyclinsignalingpromoteadiposetissuedevelopmentahumanhealthconcern
AT takahikomurata arachidonicacidandprostacyclinsignalingpromoteadiposetissuedevelopmentahumanhealthconcern
AT takuyakobayashi arachidonicacidandprostacyclinsignalingpromoteadiposetissuedevelopmentahumanhealthconcern
AT shuhnarumiya arachidonicacidandprostacyclinsignalingpromoteadiposetissuedevelopmentahumanhealthconcern
AT philippeguesnet arachidonicacidandprostacyclinsignalingpromoteadiposetissuedevelopmentahumanhealthconcern
AT ezzoubiramri arachidonicacidandprostacyclinsignalingpromoteadiposetissuedevelopmentahumanhealthconcern
AT raymondnegrel arachidonicacidandprostacyclinsignalingpromoteadiposetissuedevelopmentahumanhealthconcern
AT gerardailhaud arachidonicacidandprostacyclinsignalingpromoteadiposetissuedevelopmentahumanhealthconcern
_version_ 1721507010363523072
spelling doaj-47992fd004a24cb58505437401a597292021-04-27T04:39:21ZengElsevierJournal of Lipid Research0022-22752003-02-01442271279Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern?Florence Massiera0Perla Saint-Marc1Josiane Seydoux2Takahiko Murata3Takuya Kobayashi4Shuh Narumiya5Philippe Guesnet6Ez-Zoubir Amri7Raymond Negrel8Gérard Ailhaud9Institut de Recherche Signalisation, Biologie du Développement et Cancer, Centre de Biochimie (UMR6543CNRS), UNSA, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France; Centre Médical Universitaire, Département de Physiologie, 1 rue Michel Servet, 1211 Genève 4, Switzerland; Department of Pharmacology, Kyoto University, Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606-8315, Japan; Laboratoire de Nutrition et Sécurité Alimentaire, INRA, 78352 Jouy-en-Josas, FranceInstitut de Recherche Signalisation, Biologie du Développement et Cancer, Centre de Biochimie (UMR6543CNRS), UNSA, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France; Centre Médical Universitaire, Département de Physiologie, 1 rue Michel Servet, 1211 Genève 4, Switzerland; Department of Pharmacology, Kyoto University, Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606-8315, Japan; Laboratoire de Nutrition et Sécurité Alimentaire, INRA, 78352 Jouy-en-Josas, FranceInstitut de Recherche Signalisation, Biologie du Développement et Cancer, Centre de Biochimie (UMR6543CNRS), UNSA, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France; Centre Médical Universitaire, Département de Physiologie, 1 rue Michel Servet, 1211 Genève 4, Switzerland; Department of Pharmacology, Kyoto University, Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606-8315, Japan; Laboratoire de Nutrition et Sécurité Alimentaire, INRA, 78352 Jouy-en-Josas, FranceInstitut de Recherche Signalisation, Biologie du Développement et Cancer, Centre de Biochimie (UMR6543CNRS), UNSA, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France; Centre Médical Universitaire, Département de Physiologie, 1 rue Michel Servet, 1211 Genève 4, Switzerland; Department of Pharmacology, Kyoto University, Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606-8315, Japan; Laboratoire de Nutrition et Sécurité Alimentaire, INRA, 78352 Jouy-en-Josas, FranceInstitut de Recherche Signalisation, Biologie du Développement et Cancer, Centre de Biochimie (UMR6543CNRS), UNSA, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France; Centre Médical Universitaire, Département de Physiologie, 1 rue Michel Servet, 1211 Genève 4, Switzerland; Department of Pharmacology, Kyoto University, Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606-8315, Japan; Laboratoire de Nutrition et Sécurité Alimentaire, INRA, 78352 Jouy-en-Josas, FranceInstitut de Recherche Signalisation, Biologie du Développement et Cancer, Centre de Biochimie (UMR6543CNRS), UNSA, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France; Centre Médical Universitaire, Département de Physiologie, 1 rue Michel Servet, 1211 Genève 4, Switzerland; Department of Pharmacology, Kyoto University, Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606-8315, Japan; Laboratoire de Nutrition et Sécurité Alimentaire, INRA, 78352 Jouy-en-Josas, FranceInstitut de Recherche Signalisation, Biologie du Développement et Cancer, Centre de Biochimie (UMR6543CNRS), UNSA, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France; Centre Médical Universitaire, Département de Physiologie, 1 rue Michel Servet, 1211 Genève 4, Switzerland; Department of Pharmacology, Kyoto University, Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606-8315, Japan; Laboratoire de Nutrition et Sécurité Alimentaire, INRA, 78352 Jouy-en-Josas, FranceInstitut de Recherche Signalisation, Biologie du Développement et Cancer, Centre de Biochimie (UMR6543CNRS), UNSA, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France; Centre Médical Universitaire, Département de Physiologie, 1 rue Michel Servet, 1211 Genève 4, Switzerland; Department of Pharmacology, Kyoto University, Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606-8315, Japan; Laboratoire de Nutrition et Sécurité Alimentaire, INRA, 78352 Jouy-en-Josas, FranceInstitut de Recherche Signalisation, Biologie du Développement et Cancer, Centre de Biochimie (UMR6543CNRS), UNSA, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France; Centre Médical Universitaire, Département de Physiologie, 1 rue Michel Servet, 1211 Genève 4, Switzerland; Department of Pharmacology, Kyoto University, Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606-8315, Japan; Laboratoire de Nutrition et Sécurité Alimentaire, INRA, 78352 Jouy-en-Josas, FranceInstitut de Recherche Signalisation, Biologie du Développement et Cancer, Centre de Biochimie (UMR6543CNRS), UNSA, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France; Centre Médical Universitaire, Département de Physiologie, 1 rue Michel Servet, 1211 Genève 4, Switzerland; Department of Pharmacology, Kyoto University, Faculty of Medicine, Yoshida, Sakyo-ku, Kyoto 606-8315, Japan; Laboratoire de Nutrition et Sécurité Alimentaire, INRA, 78352 Jouy-en-Josas, FranceHigh fat intake is associated with fat mass gain through fatty acid activation of peroxisome proliferator-activated receptors δ and γ, which promote adipogenesis. We show herein that, compared to a combination of specific agonists to both receptors or to saturated, monounsaturated, and ω-3 polyunsaturated fatty acids, arachidonic acid (C20:4, ω-6) promoted substantially the differentiation of clonal preadipocytes. This effect was blocked by cyclooxygenase inhibitors and mimicked by carbacyclin, suggesting a role for the prostacyclin receptor and activation of the cyclic AMP-dependent pathways that regulate the expression of the CCAAT enhancer binding proteins β and δ implicated in adipogenesis. During the pregnancy-lactation period, mother mice were fed either a high-fat diet rich in linoleic acid, a precursor of arachidonic acid (LO diet), or the same isocaloric diet enriched in linoleic acid and α-linolenic acid (LO/LL diet). Body weight from weaning onwards, fat mass, epididymal fat pad weight, and adipocyte size at 8 weeks of age were higher with LO diet than with LO/LL diet. In contrast, prostacyclin receptor-deficient mice fed either diet were similar in this respect, indicating that the prostacyclin signaling contributes to adipose tissue development.These results raise the issue of the high content of linoleic acid of i) ingested lipids during pregnancy and lactation, and ii) formula milk and infant foods in relation to the epidemic of childhood obesity.http://www.sciencedirect.com/science/article/pii/S0022227520312141prostacyclin receptor-deficient miceadipogenesispregnancy-lactationchildhood obesity